Karl Yeh

I just want to point that out.

And that's the thing is, though, it's not something that, like, we could find applications, but it's not like you can just deploy it to any platform.

Like you can deploy it individually, no problems, no issues, right?

But when you start trying to deploy it to whether it's business or multiple groups, impacting groups, I think I'm just more and more our entire world and our entire systems, it was never built for that.

Like they were never built for...

cowork just ran doing things for you for these ages, just going in and doing like, it's never built for that.

And we're just, we're just trying to apply it.

But I'm like, I haven't even thought of like, what can I do with it that I don't like completely redesign my entire, like, yeah, it's kind of crazy, but I can, I can get back to the point of all these anti AI.

It's like interesting.

It was just an interesting conversation.

I was like, oh.

Talking it that way.

Yeah.

I don't know.

I would never, ever call myself that.

That would be something.

I did tell my OpenClaw to deploy or register, I don't know, 10,000 agents into MoldBook yesterday, which I think it did.

I have to open my VM again, but it's a pain in the neck for me because it's like I can't just switch it and obviously...

There's no way in hell I'm giving this thing access to any of my systems just because it's super integrated to client systems, which there's just no way.

I'm not even touching that.